Recent studies have found high amounts of bacteria hitching a ride on healthcare worker uniforms. While special antimicrobial fabrics are being developed to combat this problem, a team of scientists in Washington, D.C. is developing new test methods to evaluate the emerging technologies.
The American Society of Testing and Materials (ASTM) 32nd Symposium on Pesticide Formulation and Delivery: Innovating Legacy Products for New Uses, held in Tampa recently, invited a team from MedStar Health Research Institute to present its work titled, The Fabric Challenge Assays: a Novel Standard for the Evaluation of the Performance of Antimicrobial Textiles.
Antimicrobial textiles are gaining interest in healthcare settings, says Matthew Hardwick, PhD, director of laboratory of clinical investigations at MedStar Health who presented to the ASTM Committee. New product categories, especially in healthcare, need to be vetted for safety and efficacy.
While there are several standard methods available for testing antimicrobial textile efficacy, each is limited due to the artificial nature of the testing method. Our team at MedStar Health wanted to develop a test that showed the efficacy of these fabrics in terms of reducing bacterial load in real-world scenarios, explains Hardwick.
In the real world clinical environment, there are three primary means of transmission of bacteria: aqueous splatter such as urine or blood; aerosol such as a cough or sneeze; and direct contact with infected persons or environmental surfaces. The novel fabric challenge assay is designed to mimic each mode of transmission in order to test the efficacy of antimicrobial textiles in a more real-world simulation.Â
Â
Our results show that the test fabric, which was treated with Semeltec antimicrobial and provided by Vestex, reduced methicillin-resistant Staphylococcus aureus (MRSA) by different percentages for different contact simulations -- 99 percent for aerosol, 99.9 percent for direct contact and 99.9 percent for splatter conditions, Hardwick says. The different inoculation simulations also had different kill-time curves the Semeltec antimicrobial fabric from Vestex worked immediately in all tests. The control fabric did not have appreciable reductions in bacteria with any test method.
As technologies advance, our test methods must advance. The closer we get in the lab to mimicking actual use conditions, the more useful the test, says Margaret Cotton, an author of the study.Â
Â
Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.